Daunomac (Daunorubicin) is an anthracycline antibiotic that is widely used as a chemotherapy drug. It is primarily indicated for the treatment of certain types of leukemia, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). It works by interfering with the growth of cancer cells, eventually leading to their destruction.

Uses

Acute Myeloid Leukemia (AML):

• Used in combination with other chemotherapeutic agents for remission induction.

Acute Lymphoblastic Leukemia (ALL):

• Often part of combination chemotherapy regimens.

Other Cancers:

• Occasionally used in the treatment of other cancers as determined by a healthcare professional.

Daunorubicin intercalates into DNA strands, inhibiting the synthesis of nucleic acids. Additionally, it generates free radicals that damage the DNA and cell membranes, leading to cancer cell death.